NOT KNOWN FACTUAL STATEMENTS ABOUT ABBV-744 PRECLINICAL STUDIES AND RESULTS

In Phase A, individuals will receive distinctive doses and schedules of oral ABBV-744 pill to establish Safe and sound dosing routine. Further participants might be enrolled with the recognized monotherapy dosign program. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will probably be offered as "incorporate-on" therapy. In Ph